|
|
 |
|
|
|
|
|
|
|
|
|
ANNOUNCEMENTS |
|
|
|
1. Epic Clinical Applications for Research |
|
Although Clinical Ambulatory practices will Go Live with the new Epic clinical functionality beginning in December of 2015, Clinical Research activities/processes WILL NOT CHANGE from current practices until the full implementation of the Epic clinical applications on April 2nd, 2016. You will continue to see all notes and test results in the existing electronic medical record.
The clinical research community will receive comprehensive Epic training via e-Learning modules in preparation for April 2, 2016 launch of Epic clinical systems throughout MGH. Comprehensive Epic e-Learning modules will include training on new Epic procedures for ordering ancillary tests related to research protocols (laboratory, radiology, cardiology, etc.)
|
|
|
|
2. Important Information Regarding Adobe Acrobat Licensing |
|
On November 15, 2015, Adobe will no longer offer patches or bug fixes for Adobe Acrobat X. Anyone using this product for legal or confidential purposes will need to upgrade to the latest version to make sure they are not affected by security issues. Partners HealthCare employees can save 15% on the newest version of Adobe Acrobat DC Standard or Professional software when 6+ licenses are purchased on one Purchase Order (PO). This Adobe promotion applies to new licenses, perpetual or subscription, and to upgrades from perpetual Acrobat X or XI licenses and lasts until November 27, 2015. Perpetual licenses are desktop licenses with a one-time fee; subscription licenses include cloud services. Request a quote through Insight, Partners' software vendor at Partners@insight.com or 1.800.467.4448. Visit the Acrobat FAQ webpage for more information. |
|
|
|
3. Personnel Transactions: NEW Insight Hyperlink now LIVE |
|
The Insight Hyperlink will now appear on all Personnel Transactions in PeopleSoft effective Wednesday October 7, 2015 @ 3:15 pm. The hyperlink will take submitters and approvers of RPOs/EDCs to the Financial Details page in Insight for those funds within the PeopleSoft transaction. There is no need to log back in if already logged in to Insight or InfoEd. Securities are still in effect and therefore will not see financial data unless you have access to the fund.
This quick and easy connection helps submitters and approvers review funds more efficiently before submitting and approving personnel transactions. All information for each fund is now at your fingertips!
If you have any questions and or concerns, please contact Anthony Cassese (e) acassese@partners.org (p) 617.954.9589. Click here for more information.
|
|
|
|
4. NIH Update: NIH Names New Deputy Director for Extramural Research; Indirect Costs 101; Civil Rights and Research; Review Your Grant Data in Commons |
|
Please click here to read the NIH Extramural Nexus.
|
|
|
|
|
|
EVENTS |
|
|
|
1. MGH Special Seminar |
|
Tuesday, October 13, 2015, 4:00 - 5:00pm, Starr Center (Schepens Eye Research Institute), 185 Cambridge Street, 2nd Floor, Boston, MA
Sponsored by the Seminars in Cell Biology, Division of Nephrology and the Department of Neurology
Ana Maria Cuervo, Ph.D.
Robert and Renée Belfer Chair for the Study of Neurodegenerative Disease
Professor of Developmental and Molecular Biology; Anatomy and Structural Biology; and Medicine
Albert Einstein College of Medicine
Hosts: Roy Soberman (Nephrology, 6-3747), Breen Power (Neurology, 6-1275)
|
|
|
|
2. Research Navigator October Q & A Sessions |
|
The Navigator team will be hosting information sessions in October to all who are interested at MGH. Stop by during one of the sessions below to learn more about Navigator and how it can help you, and about exciting enhancements like the new contact directory and improved search feature.
MGH employees can attend all or part of any session (2 hour time commitment is not necessary):
-
Tuesday, 10/13 @ MGH Haber Auditorium (1-3pm)
-
Thursday, 10/15 @ 149 Charlestown Navy Yard (10am-12pm in room 2204)
If you are interested in attending, please sign up here, or email researchnavigator@partners.org with the session you would like to attend.
|
|
|
|
|
|
FUNDING OPPORTUNITIES |
|
|
|
1. The MGH Claflin Distinguished Scholar Awards |
|
Applications are now being accepted by the Executive Committee on Research (ECOR) for the Claflin Distinguished Scholar Awards!
What are the Claflin Awards?
Although women scientists are recruited to Massachusetts General Hospital (MGH) programs, their advancement to senior faculty positions is still far less frequent than that of their male counterparts. In 1993, The Women in Academic Medicine Committee, originally chaired by Mrs. R. Morton Claflin, Honorary Trustee, was established to facilitate the academic careers of women in science at MGH. Recognizing that a significant obstacle to career advancement is the difficulty of maintaining research productivity during the child-rearing years, this Committee, with the sponsorship of the Executive Committee On Research (ECOR), established the Claflin Distinguished Scholar Awards. It is intended that this transitional funding will increase opportunities for women to advance to senior positions in academic medicine.
How much is each award?
These are two year awards for $50,000 per year in direct costs, plus 15% for indirect costs.
When is the deadline?
Tuesday, October 13, 2015 - 5:00 PM
How do I learn more and apply?
Click here to read more and apply online!
|
|
|
|
2. Fall 2015 nomination process for the HMS Foundation Fund |
|
The HMS Foundation Funds Program administers the nomination process for HMS/HSDM faculty and postdocs for funding opportunities from private foundations that require candidates to be nominated by either Harvard Medical School or Harvard University. Each year, several foundations invite HMS/HSDM junior faculty members and postdocs to apply for their fellowships and grants, which serve as critical funding at the early stages of a research career. Interested investigators must first apply internally through the HMS Foundation Funds, and a committee will select the final candidates who will then submit applications to the foundations.
Additionally, a number of funding opportunities are available solely to our faculty. These are different from the typical Foundation Funds awards because applicants do not go on to compete against applicants from other universities at the national level, and therefore no institutional nomination is required. More information on these awards can be found in the award listings.
Information on funding opportunities offered through the HMS Foundation Funds office is available online at: www.hms.harvard.edu/foundationfunds
Awards include:
-
Brain Research Fund Fay/Frank Seed Grant Program
-
Breast Cancer Alliance Exceptional Project Grant**
-
Dana Foundation David Mahoney Neuroimaging Program
-
Damon Runyon Clinical Investigator Award
-
Macy Foundation Faculty Scholars Program
-
Mary Kay Innovative/Translational Cancer Research Award
-
Packard Fellowships in Science and Engineering
-
Rita Allen Faculty Scholars Program
Faculty and postdocs interested in applying for any of the awards listed above can apply for the HMS nomination by submitting an application online no later than October 15, 2015 at 5:00PM.
**Note: If you are an MGH investigator, you should not apply directly to HMS for several of the funding opportunities offered through the HMS Foundation Funds office throughout the year. Please click herefor more information on how to determine where to apply and for information on the process.
Please direct all inquiries to the Office of the HMS Dean for Academic and Clinical Affairs, 617-432-7463, hmsaca@hms.harvard.edu. For any questions regarding the process for receiving the MGH institutional nomination to apply for any limited submission funding opportunity, please contact Erin McGivney at emcgivney@partners.org or 617-643-6471.
|
|
|
|
3. Bullock Postdoctoral Fellowship |
|
The Wellman Center for Photomedicine at the Massachusetts General Hospital is pleased to invite applications for the Bullock postdoctoral fellowship for research aimed at understanding and solving important biomedical problems. PhD, MD and MD PhD research fellows are eligible for this award.
This multidisciplinary fellowship was created to foster interactions between researchers from diverse fields of science and medicine. Combined mentorship and collaboration between two Harvard Medical School faculty members, at least one of whom is based at the Wellman Center, is required. An external collaborator is preferred. It is anticipated that the fellow will perform the majority of their research at the Wellman Center. For additional information regarding the Wellman Center please visit http://www.massgeneral.org/wellman/.
The Fellowship will provide one year of support. An award of up to $60,000 direct costs is anticipated. The award will be administered by the Wellman Center. Funds may be used for stipend (minimum effort 60%), fringe benefits and research supplies. Recipients will be required to submit periodic progress reports, present their work at a noon lecture and submit a final written report
Criteria for funding are scientific quality, an enabling collaboration that might not occur otherwise, potential medical and scientific impact, and career development of the Fellow.
Please click here for eligibility and other award information.
Deadline: No later than 5 pm on November 2, 2015.
Questions can be addressed via e-mail to BullockFellowship@partners.org
|
|
|
|
4. Boston Area Diabetes Endocrinology Research Center Pilot and Feasibility Research Grants |
|
The Boston Area Diabetes Endocrinology Research Center is now accepting Pilot and Feasibility Research Grant Award Applications for studies of Diabetes Mellitus and Its Complications
The Boston Area Diabetes Endocrinology Research Center is funded by the National Institute of Diabetes and Digestive Diseases (NIDDK) to support research in Diabetes and its complications. Research grants up to $30,000 will be awarded for meritorious proposals from candidates whose eligibility is defined by one or more of the following three criteria:
1. Junior faculty without past or current NIH support to conduct Diabetes research.
Not eligible if you have any support that is mandatory 100% effort where you cannot accept any federal funding.
2. Established non-Diabetes researchers who have an innovative idea relevant to Diabetes.
3. Established Diabetes investigators who have an innovative idea/approach relevant to Diabetes that represents a distinct departure from their established line of investigation.
4. Co-PI’s are not allowed, and if you are not accepting salary and or less than 5%, please mention if there is cost sharing.
It is anticipated that up to four meritorious applications will be funded.
Letters of Intent, Biosketch, Other support and Abstract due October 21, 2015
If proposal accepted,
Applications due by December 2, 2015
If you qualify based on one of the three criteria listed above, please email a letter of intent in MS Word that includes your name, degree, title and email address and a brief description of your research. In addition to the LOI email, please include an abstract with the title of your project (NIH form page) of your research, a biosketch and OS page. If your proposed research is deemed compatible with the goals of the BADERC, instructions for the preparation of a five-page application for a Pilot and Feasibility Research Grant Award will be forwarded to you. The deadline for the Grant application will be December 2, 2015. Funding will be effective April 1, 2016.
Please send Letters of Intent and abstract page with the title of your project in word via (email) to Prendable@molbio.mgh.harvard.edu
|
|
|
|
5. Private Funding Opportunities |
|
Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.
-
Grant Program, Alcoholic Beverage Medical Research Foundation (ABMRF)
-
Epidemiology Grants, Alex’s Lemonade Stand Foundation for Childhood Cancer (ALSF)
-
Innovation Awards, Alex’s Lemonade Stand Foundation for Childhood Cancer (ALSF)
-
Young Investigator Awards, Alex’s Lemonade Stand Foundation for Childhood Cancer (ALSF)
-
Opportunities to Accelerate Funding for Drug Discovery and Development for Alzheimer's Disease, Cognitive Aging and Related Disorders, Alzheimer's Drug Discovery Foundation (ADDF)
-
AFSP Annual Grant Cycle: Postdoctoral Research Fellowships, American Foundation for Suicide Prevention (AFSP)
-
IRP Research Grant, International Foundation for Research in Paraplegia (IRP)
-
IRP Schellenberg Research Prize, International Foundation for Research in Paraplegia (IRP)
-
NBF Scientific Research Grants Program, National Blood Foundation (NBF)
-
Research Grant, Oxalosis and Hyperoxaluria Foundation (OHF)
-
Therapeutic Development Initiative (TDI) - Funding for High-Impact Pediatric Cancer Research, Solving Kids' Cancer
Please click here for further details on these funding opportunities.
|
|
|
|
6. Limited Submission Funding Opportunities |
|
We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.
Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org. In addition to your LOI, please include an NIH Biosketch.
The letter of intent should include:
-
Name of the Principal Investigator with appropriate contact information
-
A descriptive title of the potential application
-
Brief description of the project
-
Brief description of why you specifically should be selected to receive institutional nomination for this award
In the event that there is more than one MGH investigators interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.
Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.
-
Child Neurologist Career Development Program (CNCDP) (K12)
-
NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research on Chronic Disease Prevention (U54)
-
Superfund Hazardous Substance Research and Training Program (P42)
If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please contact Erin McGivney at 617-643-6471.
|
|
|
|
7. NIH Update for Week Ending October 9, 2015 |
|
For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm
|
|
|
|
|
|
In Case You Missed It |
|
|
|
Reminders of recently posted funding opportunities, deadlines and events |
|
MGH Claflin Distinguished Scholar Awards
Application Deadline: October 13
Center for the Study of Inflammatory Bowel Disease (CSIBD) Pilot/Feasibility Study Grants
Application Deadline: October 13
Innovation Travel Award
Application Deadline: October 15
Pfizer Centers for Therapeutic Innovation 2015
Application Deadline: October 16
MGH ECOR Formulaic Bridge Support
Application Deadline: November 7, 7th day of each month
The MGH Research Scholars Program
Application Deadline: November 10
Massachusetts Eye and Ear Gliklich Innovation Scholars Program
Application Deadline: February 1, 2016
Boston Biomedical Innovation Center (B-BIC) Accepting PILOT & DRIVE Grant Pre-Proposals
Looking for something you saw in a previous Research News release? Check out our archive!
|
|
|
|
|
|
|
|
|
|
|